The patient panel will kick off the discussion in the morning, and will be followed by a large-facilitated discussion with patients and caregivers from the audience. So we encourage you to share your experience during the large-facilitated discussion portion of the workshop. The workshop is in-tended to be an opportunity for FDA to hear directly from patients, and we make every effort to make sure the voice of the patient is heard.
We also encourage you to submit your comments directly to our “public docket”. This is a website through which patients living with EPP and oth-ers can share their experiences and perspectives. These comments supple-ment the input we get from the workshop. We will review all of these com-ments. To submit your comment, visit:
https://www.regulations.gov/document?D=FDA-2016-N-1493-0001. Click on the “Comment Now” button in the top-right corner. You will be able to upload a PDF or Word version of your comments.